HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sharfstein Says Spiked Products Top FDA Supplement Enforcement Goals

This article was originally published in The Tan Sheet

Executive Summary

FDA Principal Deputy Commissioner Josh Sharfstein says that two to-do lists sit on his desk - one of urgent priorities that the agency must address immediately and one of important tasks that can wait

You may also be interested in...



FDA warns consumers about Que She

FDA warns consumers to stop using the weight-loss capsules Que She and consult health care providers because the product contains undeclared active pharmaceutical ingredients that could endanger people with heart conditions. Undeclared ingredients include the Rx weight-loss ingredient sibutramine, which can increase the risk of heart attack and stroke, and the stimulant fenfluramine, which was removed from the U.S. market in 1997 after studies showed it damaged heart valves. The Rx beta blocker propranolol and the stimulant ephedrine also were found in the capsules and pose a risk to people with heart conditions, FDA said July 8. Principal Deputy Commissioner Josh Sharfstein said removing "spiked" supplements from the market is a priority (1"The Tan Sheet" Oct. 26, 2009)

FDA Lifts Curtain On The Secret Behind Magic Power Coffee

FDA's consumer advisory against a coffee product that contains an active drug ingredient for erectile dysfunction reflects the agency's growing capability to keep up with noncompliant firms that add drug substances to so-called dietary supplements

FDA Plays Misdemeanor Card In Adulterated Supplement Prosecution

FDA's Office of Criminal Investigations assists in prosecuting the maker of "all-natural" sexual enhancement drugs, an action in line with its strategy to seek more misdemeanor charges against violative food and drug firms

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135981

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel